Micro spies from the brain to the periphery: New clues from studies on microRNAs in neuropsychiatric disorders

Frontiers in Cellular Neuroscience

Volumn 8, Issue MAR, 2014, Pages

  Maffioletti, Elisabetta ^a,b   Tardito, Daniela ^c   Gennarelli, Massimo ^a,b   Bocchio Chiavetto, Luisella ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer disease; Bipolar disorder; Genetic variation; Major depression; microRNA; Parkinson disease; Schizophrenia; SNP

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 107; MICRORNA 132; MICRORNA 134; MICRORNA 181B; MICRORNA 26; MICRORNA 26B; MICRORNA 34A; MICRORNA 34C; MICRORNA 9; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANXIETY; ARTICLE; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM FUNCTION; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPSYCHIATRIC DISORDER; NEUROPSYCHIATRY; NEUROTRANSMITTER RELEASE; PARKINSON DISEASE; PATHOPHYSIOLOGY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

EID: 84896970969     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00075     Document Type: Article

References (154)

1. Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., et al. (2005). Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310, 317-320. doi: 10.1126/science.1116502.
2. Absalon, S., Kochanek, D. M., Raghavan, V., and Krichevsky, A. M. (2013). MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J. Neurosci. 33, 14645-14659. doi: 10.1523/JNEUR0SCI.1327-13.2013.
3. Alexandrov, P. N., Dua, P., Hill, J. M., Bhattacharjee, S., Zhao, Y., and Lukiw, W.J. (2012). microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3, 365-373.
4. Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., et al. (2011). Argonaute2 complexes carry a population of circulating microR-NAs independent ofvesicles in human plasma. Proc. Natl. Acad. Sci. U.S.A. 108, 5003-5008. doi: 10.1073/pnas.1019055108.
5. Banigan, M. G., Kao, P. F., Kozubek, J. A., Winslow, A. R., Medina, J., Costa, J., et al. (2013). Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS ONE 8:e48814. doi: 10.1371/journal.pone.0048814.
6. Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J. M., and Kellermann, O. (2010). miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 329, 1537-1541. doi: 10.1126/sci-ence.1193692
7. Begemann, M., Grube, S., Papiol, S., Malzahn, D., Krampe, H., Ribbe, K., et al. (2009). Modification of cognitive performance in schizophrenia by complexin gene polymorphisms. Arch. Gen. Psychiatry 67, 879-888. doi: 10.1001/arch-genpsychiatry.2010.107.
8. Belzeaux, R., Bergon, A., Jeanjean, V., Loriod, B., Formisano-Treziny, C., Verrier, L., et al. (2012). Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl. Psychiatry 2, e185. doi: 10.1038/tp.2012.112.
9. Beveridge, N. J., Gardiner, E., Carroll, A. P., Tooney, P. A., and Cairns, M. J. (2010). Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 15, 1176-1189. doi: 10.1038/mp.2009.84.
10. Beveridge, N. J., Tooney, P. A., Carroll, A. P., Gardiner, E., Bowden, N., Scott, R. J., et al. (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum. Mol. Genet. 17, 1156-1168. doi: 10.1093/hmg/ddn005.
11. Bicker, S., Khudayberdiev, S., Wei CK., Zocher, K., Baumeister, S., and Schratt, G. (2013). The DEAH box helicase DHX36 mediates dendritic localization of the neuronal precursor-microRNA-134. Genes Dev. 27, 991-996. doi: 10.1101/gad.211243.112.
12. Blennow, K., and Zetterberg, H. (2013). The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease. Med. Clin. North Am. 97, 369-376. doi: 10.1016/j.mcna.2012.12.012.
13. Bocchio-Chiavetto, L., Maffioletti, E., Bettinsoli, P., Giovannini, C., Bignotti, S., Tardito, D., et al. (2013). Blood microRNA changes in depressed patients during antidepressant treatment. Eur. Neuropsychopharmacol. 23, 602-611. doi: 10.1016/j.euroneuro.2012.06.013
14. Boeckel, J. N., Thome C. E., Leistner, D., Zeiher, A. M., Fichtlscherer, S., and Dimmeler, S. (2013). Heparin selectively affects the quantification of microRNAs in human blood samples. Clin. Chem. 59, 1125-1127. doi: 10.1373/clinchem.2012.199505.
15. Boutajangout, A., and Wisniewski, T. (2013). The innate immune system in Alzheimer's disease. Int. J. Cell Biol. 2013, 576383. doi: 10.1155/2013/576383.
16. Breving, K., and Esquela-Kerscher, A. (2010). The complexities of microRNA regulation: mirandering aroundthe rules. Int. J. Biochem. CellBiol. 42, 1316-1329. doi: 10.1016/j.biocel.2009.09.016.
17. Burgos, K. L., Javaherian, A., Bomprezzi, R., Ghaffari, L., Rhodes, S., Courtright, A., et al. (2013). Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing. RNA 19, 712-722. doi: 10.1261/rna. 036863.112
18. Caputo, V., Sinibaldi, L., Fiorentino, A., Parisi, C., Catalanotto, C., Pasini, A., et al. (2011). Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR 26a and miR-26b allele-specific binding. PLoS ONE 6:e28656. doi: 10.1371/journal.pone.0028656.
19. Chan, A. W., and Kocerha, J. (2012). The path to microRNA therapeutics in psychiatric and neurodegenerative disorders. Front. Genet. 3:82. doi: 10.3389/fgene.2012.00082.
20. Chekulaeva, M., and Filipowicz, W. (2009). Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell Biol. 21, 452-460. doi: 10.1016/j.ceb.2009.04.009.
21. Chen, H., Wang, N., Burmeister, M., and McInnis, M. G. (2009). MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int. J. Neuropsychopharmacol. 12, 975-981. doi: 10.1017/S1461145709000029.
22. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006. doi: 10.1038/cr.2008.282.
23. Chen-Plotkin, A. S., Unger, T. L., Gallagher, M. D., Bill, E., Kwong, L. K., Volpicelli-Daley, L., et al. (2012). TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progran-ulin pathways. J. Neurosci. 32, 11213-11227. doi: 10.1523/JNEUROSCI.0521-12.2012
24. Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., et al. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14, 27-41.
25. Cortez, M. A., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A. K., and Calin, G. A. (2011). MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 8, 467-477. doi: 10.1038/nrclinonc.2011.76.
26. Creson, T. K., Austin, D. R., Shaltiel, G., McCammon, J., Wess, J., Manji, H. K., et al. (2011). Lithium treatment attenuates muscarinic M(1) receptor dysfunction. BipolarDisord. 13, 238-249. doi: 10.1111/j.1399-5618.2011.00915.x
27. Cummings, E., Donohoe, G., Hargreaves, A., Moore, S., Fahey, C., Dinan, T., et al. (2013). Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137. Neurosci. Lett. 532, 33-38. doi: 10.1016/j.neulet.2012.08.065.
28. Davis, B. N., and Hata, A. (2009). Regulation of microRNA biogenesis: a miRiad of mechanisms. Cell Commun. Signal. 7, 18. doi: 10.1186/1478-811X-7-18.
29. Delay, C., Calon, F., Mathews, P., and Hebert, S. S. (2011). Alzheimer-specific variants in the 3 UTR of Amyloid precursor protein affect microRNA function. Mol. Neurodegener. 6, 70. doi: 10.1186/1750-1326-6-70
30. de Mena, L., Cardo, L. F., Coto, E., Miar, A., Diaz, M., Corao, A. I., et al. (2009).FGF20 rs12720208. SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients. Neurosci. Lett. 479, 22-25. doi: 10.1016/j.neulet.2010.05.019
31. Doxakis, E. (2010). Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J. Biol. Chem. 285, 12726-12734. doi: 10.1074/jbc.M109.086827.
32. Duan, S., Mi, S., Zhang, W., and Dolan, M. E. (2009). Comprehensive analysis ofthe impact of SNPs and CNVs on human microRNAs and their regulatory genes. RNABiol. 6, 412-425. doi: 10.4161/rna.6.4.8830.
33. Farazi, T. A., Hoell, J. I., Morozov, P., and Tuschl, T. (2013). MicroRNAs in human cancer. Adv. Exp. Med. Biol. 774, 1-20. doi: 10.1007/978-94-007-5590-1_1.
34. Felekkis, K., Voskarides, K., Dweep, H., Sticht, C., Gretz, N., and Deltas, C. (2007).Increased number of microRNA target sites in genes encoded in CNV regions. Evidence for an evolutionary genomic interaction. Mol. Biol. Evol. 14, 2421-2424. doi: 10.1093/molbev/msr078
35. Feng, J., Sun, G., Yan, J., Noltner, K., Li, W., Buzin, C. H., et al. (2009). Evidence for X-chromosomal schizophrenia associated with microRNA alterations. PLoS ONE 4:e6121. doi: 10.1371/journal.pone.0006121.
36. Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., et al. (2006). Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677-684. doi: 10.1161/CIRCRESAHA.109.215566.
37. Gao, F. B. (2010b). Context-dependent functions of specific microRNAs in neuronal development. Neural Dev. 5, 25. doi: 10.1186/1749-8104-5-25.
38. Gao, J., Wang, W.Y., Mao, Y. W., Graff, J., Guan, J. S., Pan, L., et al. (2010a).Anovel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 466, 1105-1109. doi: 10.1038/nature09271.
39. Gardiner, E., Beveridge, N. J., Wu, J. Q., Carr, V., Scott, R. J., Tooney, P. A., et al. (2012). Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Mol. Psychiatry 17, 827-840. doi: 10.1038/mp.2011.78.
40. Gaughwin, P., Ciesla, M., Yang, H., Lim, B., and Brundin, P. (2011). Stage-specific modulation of cortical neuronal development byMmu-miR-134. Cereb. Cortex 21, 1857-1869. doi: 10.1093/cercor/bhq262.
41. Geekiyanage, H., and Chan, C. (2011). MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid 3, novel targets in sporadic Alzheimer's disease. J.Neurosci. 31, 14820-14830. doi: 10.1523/JNEUR0SCI.3883-11.2011.
42. Geekiyanage, H., Jicha, G. A., Nelson, P. T., and Chan, C. (2012). Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp. Neurol. 235, 491-496. doi: 10.1016/j.expneurol.2011.11.026.
43. Green, M. J., Cairns, M. J., Wu, J., Dragovic, M., Jablensky, A., Tooney, P. A., et al. (2013). Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. Mol. Psychiatry. 18, 774-780. doi: 10.1038/mp.2012.84.
44. Guay, C., and Regazzi, R. (2013). Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat. Rev. Endocrinol. 9, 513-521. doi:10.1038/nrendo.2013.86.
45. Guella, I., Sequeira, A., Rollins, B., Morgan, L., Torri, F., van Erp, T. G., et al. (2013). Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J. Psychiatr. Res. 47, 1215-1221. doi: 10.1016/j.jpsychires.2013.05.021.
46. Han, M., and Zheng, Y. (2013). Comprehensive analysis of single nucleotide polymorphisms in human microRNAs. PLoS ONE 8:e78028. doi: 10.1371/jour-nal.pone.0078028
47. Hanke, M., Hoefig, K., Merz, H., Feller, A. C., Kausch, I., Jocham, D., et al. (2010). A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA 182 are related to urinary bladder cancer. Urol. Oncol. 28, 655-661. doi: 10.1016/j.urolonc.2009.01.027.
48. Hansen, K. F., Karelina, K., Sakamoto, K., Wayman, G. A., Impey, S., and Obrietan, K. (2013). miRNA-132: a dynamic regulator of cognitive capacity. Brain Struct. Funct. 218, 817-831. doi: 10.1007/s00429-012-0431-4.
49. Hansen, T., Olsen, L., Lindow, M., Jakobsen, K. D., Ullum, H., Jonsson, E., et al. (2007). Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2:e873. doi: 10.1371/journal.pone.0000873.
50. Haramati, S., Navon, I., Issler, O., Ezra-Nevo, G., Gil, S., Zwang, R., et al. (2011). MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J.Neurosci. 31, 14191-14203. doi: 10.1523/JNEUROSCI.1673-11.2011.
51. Hebert, S. S., Horre, K., Nicolai', L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., et al. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 105, 6415-6420. doi: 10.1073/pnas.0710263105.
52. Hebert, S. S., Wang, W. X., Zhu, Q., and Nelson, P. T. (2013). A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non demented human controls. J. Alzheimers. Dis. 35, 335-348. doi: 10.3233/JAD-122350.
53. He, Y., Zhou, Y., Xi, Q., Cui, H., Luo, T., Song, H., et al. (2012). Genetic variations in microRNA processing genes are associated with susceptibility in depression. DNA Cell Biol 31, 1499-1506. doi: 10.1089/dna.2012.1660.
54. Hennah, W., Varilo, T., Kestila, M., Paunio, T., Arajarvi, R., Haukka, J., et al. (2003). Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum. Mol. Genet. 12, 3151-3159. doi: 10.1093/hmg/ddg341.
55. Honda, M., Kuwano, Y., Katsuura-Kamano, S., Kamezaki, Y., Fujita, K., Akaike, Y., et al. (2013). Chronic academic stress increases a group of microRNAs in peripheral blood. PLoS ONE 8:e75960. doi: 10.1371/journal.pone.0075960
56. Hu, K., Xie, Y. Y., Zhang, C., Ouyang, D. S., Long, H. Y., Sun, D. N., et al. (2012). MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci. 13:115. doi: 10.1186/1471-2202-13-115.
57. Huntzinger, E., and Izaurralde, E. (2011). Gene silencing bymicroRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12, 99-110. doi: 10.1038/nrg2936.
58. Iguchi, H., Kosaka, N., and Ochiya, T. (2010). Secretory microRNAs as a versatile communication tool. Commun. Integr. Biol. 3, 478-481. doi: 10.4161/cib.3.5.12693.
59. Jimenez-Mateos, E. M., Engel, T., Merino-Serrais, P., McKiernan, R. C., Tanaka, K., Mouri, G., et al. (2012). Silencing microRNA-134 produces neuroprotec-tive and prolonged seizure-suppressive effects. Nat. Med. 18, 1087-1094. doi: 10.1038/nm.2834
60. Junn, E., Lee, K. W., Jeong, B. S., Chan, T. W., Im, J. Y., and Mouradian, M. M. (2010). Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc. Natl. Acad. Sci. U.S.A. 106, 13052-13057. doi: 10.1073/pnas.09062 77106
61. Junn, E., and Mouradian, M. M. (2012). MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol. Ther. 133, 142-150. doi: 10.1016/j.pharmthera.2011.10.002.
62. Katsuura, S., Kuwano, Y., Yamagishi, N., Kurokawa, K., Kajita, K., Akaike, Y., et al. (2010).MicroRNAs miR-144/144* and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students. Neurosci. Lett. 516, 79-84. doi: 10.1016/j.neulet.2012.03.062
63. Kiko, T., Nakagawa, K., Tsuduki, T., Furukawa, K., Arai, H., and Miyazawa, T. (2006).MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. J. Alzheimers Dis. 39, 253-259. doi: 10.3233/JAD-130932
64. Kim, A. H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J. L., et al. (2010). MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr. Res. 124, 183-191. doi: 10.1016/j.schres.2010.07.002.
65. Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., et al. (2007). MicroRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224. doi: 10.1126/science.1140481.
66. Kolshus, E., Dalton, V. S., Ryan, K. M., and McLoughlin, D. M. (2013). When less is more -microRNAs and psychiatric disorders. Acta Psychiatr. Scand. doi: 10.1111/acps.12191. [Epub ahead ofprint].
67. Kozomara, A., and Griffiths-Jones, S. (2014). miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42, D68-D73. doi: 10.1093/nar/gkt1181
68. Kroh, E. M., Parkin, R. K., Mitchell, P. S., and Tewari, M. (2010). Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298-301. doi: 10.1016/j.ymeth.2010.01.032.
69. Krol, J., Loedige, I., and Filipowicz, W. (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610. doi: 10.1038/nrg2843
70. Lai, C. Y., Yu, S. L., Hsieh, M. H., Chen, C. H., Chen, H. Y., Wen, C. C., et al. (2011). MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS ONE 6:e21635. doi: 10.1371/journal.pone.0021635.
71. Laterza, O. F., Lim, L., Garrett-Engele, P. W., Vlasakova, K., Muniappa, N., Tanaka, W. K., et al. (2009). Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin. Chem. 55, 1977-1983. doi:10.1373/clinchem.2009. 131797
72. Lau, P., Bossers, K., Janky, R., Salta, E., Frigerio, C. S., Barbash, S., et al. (2013). Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol. Med. 5, 1613-1634. doi: 10.1002/emmm.201201974.
73. Lee, R. C., Feinbaum, R. L., and Ambros, V. (1993). The, Celegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854. doi:10.1016/0092-8674(93)90529-Y
74. Lehmann, S. M., Kruger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., et al. (2012). An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15, 827-835. doi: 10.1038/nn.3113
75. Leidinger, P., Backes, C., Deutscher, S., Schmitt, K., Mueller, S. C., Frese, K., et al. (2006). A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 14, R78. doi: 10.1186/gb-2013-14-7-r78
76. Li, Y. J., Xu, M., Gao, Z. H., Wang, Y. Q., Yue, Z., Zhang, Y. X., et al. (2013). Alterations of serum levels of BDNF-related miRNAs in patients with depression. PLoS ONE 8:e63648. doi: 10.1371/journal.pone.0063648.
77. Liu, C., Zhang, F., Li, T., Lu, M., Wang, L., Yue, W., et al. (2012b). MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics 13:661. doi: 10.1186/1471-2164-13-661.
78. Liu, N., Landreh, M., Cao, K., Abe, M., Hendriks, G. J., Kennerdell, J. R., et al. (2012a). The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482, 519-523. doi: 10.1038/nature10810.
79. Liu, S., Yuan, Y. B., Guan, L. L., Wei, H., Cheng, Z., Han, X., et al. (2013). MiRNA-365 and miRNA-520c-3p respond to risperidone treatment in first-episode schizophrenia after a 1 year remission. Chin. Med. J. (Engl.). 126, 2676-2680.
80. Madrigal-Matute, J., Rotllan, N., Aranda, J. F., and Fernandez-Hernando, C.MicroRNAs and atherosclerosis. Curr. Atheroscler. Rep. 15, 322. doi: 10.1007/s11883-013-0322-z
81. Marcinkowska, M., Szymanski, M., Krzyzosiak, W. J., and Kozlowski, P. (2011). Copy number variation of microRNA genes in the human genome. BMC Genomics 14:183. doi: 10.1186/1471-2164-12-183.
82. Margis, R., Margis, R., and Rieder, C. R. (2011). Identification of blood microRNAs associated to Parkinsonis disease. J. Biotechnol. 152, 96-101. doi: 10.1016/j.jbiotec.2011.01.023.
83. Martins, M., Rosa, A., Guedes, L. C., Fonseca, B. V., Gotovac, K., Violante, S., et al. (2011). Convergence of miRNA expression profiling, a-synuclein interacton and GWAS in Parkinson's disease. PLoS ONE 6:e25443. doi: 10.1371/jour-nal.pone.0025443
84. Miller, B. H., Zeier, Z., Xi, L., Lanz, T. A., Deng, S., Strathmann, J., et al. (2012). MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc. Natl. Acad. Sci. U.S.A. 109, 3125-3130. doi: 10.1073/pnas.1113793109.
85. Minones-Moyano, E., Porta, S., Escaramis, G., Rabionet, R., Iraola, S., Kagerbauer, L., et al. (2011). MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 20, 3067-3078. doi: 10.1093/hmg/ddr210.
86. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518. doi: 10.1073/pnas.0804549105.
87. Monsonego, A., Nemirovsky, A., and Harpaz, I. (2013). CD4T cells in immunity and immunotherapy of Alzheimer's disease. Immunology 139, 438-446. doi: 10.1111/imm.12103
88. Moreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., and Brzustowicz, L. M. (2005). Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 69, 188-193. doi: 10.1016/j.biopsych.2010.09.039.
89. Muinos-Gimeno, M., Espinosa-Parrilla, Y., Guidi, M., Kagerbauer, B., Sipila, T., Maron, E., et al. (2011). Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol. Psychiatry 69, 526-533. doi: 10.1016/j.biopsych.2010.10.010.
90. Muinos-Gimeno, M., Guidi, M., Kagerbauer, B., Martin-Santos, R., Navines, R., Alonso, P., et al. (2009). Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum. Mutat. 30, 1062-1071. doi: 10.1002/humu. 21005
91. Muinos-Gimeno, M., Montfort, M., Bayes, M., Estivill, X., and Espinosa-Parrilla, Y. (2010). Design and evaluation of apanel of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease. Eur. J. Hum. Genet. 18,218-226.doi: 10.1038/ejhg.2009.165.
92. Muller, M., Kuiperij, H. B., Claassen, J. A., Kusters, B., and Verbeek, M. M. (2006).MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol. Aging 35, 152-158. doi: 10.1016/j.neurobiolaging.2013.07.005
93. Nelson, P. T., and Wang, W. X. (2010). MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J. Alzheimers Dis. 21, 75-79. doi: 10.3233/JAD-2010-091603.
94. Numakawa, T., Richards, M., Adachi, N., Kishi, S., Kunugi, H., and Hashido, K. (2011). MicroRNA function and neurotrophin BDNF. Neurochem. Int. 59, 551-558. doi: 10.1016/j.neuint.2011.06.009
95. Nunez-Iglesias, J., Liu, C. C., Morgan, T. E., Finch, C. E., and Zhou, X. J. (2010). Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS ONE 5:e8898. doi: 10.1371/journal.pone.0008898.
96. O'Carroll, D., and Schaefer, A. (2012). General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology 38, 39-54. doi: 10.1038/npp.2012.87.
97. O'Connor, R. M., Grenham, S., Dinan, T. G., and Cryan, J. F. (2013). microRNAs as novel antidepressant targets: converging effects of ketamine and electrocon-vulsive shock therapy in the rat hippocampus. Int. J. Neuropsychopharmacol. 16, 1885-1892. doi: 10.1017/S1461145713000448.
98. Olde Loohuis, N. F., Kos, A., Martens, G. J., Van Bokhoven, H., Nadif Kasri, N., and Aschrafi, A. (2012). MicroRNA networks direct neuronal development and plasticity. Cell. Mol. LifeSci. 69, 89-102. doi: 10.1007/s00018-011-0788-1.
99. Oved, K., Morag, A., Pasmanik-Chor, M., Oron-Karni, V., Shomron, N., Rehavi, M., et al. (2012). Genome-wide miRNA expression profiling of human lym-phoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers. Pharmacogenomics 13, 1129-1139. doi: 10.2217/pgs.12.93.
100. Papoutsidakis, N., 1G., Giannopoulos, G., Theodorakis, A., et al. (2013). MicroRNAs and the heart: small things do matter. Curr. Top. Med. Chem. 13, 216-230. doi: 10.2174/1568026611313020009.
101. Park, N. J., Zhou, H., Elashoff, D., Henson, B. S., Kastratovic, D. A., Abemayor, E., et al. (2009). SalivarymicroRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 15, 5473-5477. doi: 10.1158/1078-0432.CCR-09-0736
102. Pasquinelli, A. E. (2012). MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet. 13, 271-282. doi: 10.1038/nrg3162
103. Pelizzari, M., Tardito, D., Mallei, A., Corna, S., Treccani, G., Bocchio-Chiavetto, L., et al. (2012). Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants. Eur. Neuropsychopharmacol. 22, S101-S102. doi: 10.1016/S0924-977X(12)70108-6.
104. Peng, Z., Li, J., Li, Y., Yang, X., Feng, S., Han, S., et al. (2013). Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1. J. Neurosci. Res. 91, 1349-1362. doi: 10.1002/jnr.23255
105. Perkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., et al. (2007). microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 8, R27. doi: 10.1186/gb-2007-8-2-r27.
106. Perkins, D. O., Jeffries, C., and Sullivan, P. (2005). Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia. Mol. Psychiatry 10, 69-78. doi: 10.1038/sj.mp. 4001577
107. Pigati, L., Yaddanapudi, S. C., Iyengar, R., Kim, D. J., Hearn, S. A., Danforth, D., et al. (2010). Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 5:e13515. doi: 10.1371/jour-nal.pone.0013515
108. Profumo, V., and Gandellini, P. (2013). MicroRNAs: cobblestones on the road to cancer metastasis. Crit. Rev. Oncog. 18, 341-355. doi: 10.1615/CritRevOncog.2013007182.
109. Rademakers, R., Eriksen, J. L., Baker, M., Robinson, T., Ahmed, Z., Lincoln, S. J., et al. (2008). Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 17, 3631-3642. doi: 10.1093/hmg/ddn257.
110. Rahman, O. A., Sasvari-Szekely, M., Szekely, A., Faludi, G., Guttman, A., and Nemoda, Z. (2010). Analysis of a polymorphic microRNA target site in the purinergic receptor P2RX7 gene. Electrophoresis 31, 1790-1795. doi: 10.1002/elps.200900664.
111. Ripke, S., Sanders, A. R., Kendler, K. S., Levinson, D. F., Sklar, P., Holmans, P. A., et al. (2011). Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976. doi: 10.1038/ng.940.
112. Rong, H., Liu, T. B., Yang, K. J., Yang, H. C., Wu, D. H., Liao, C. P., et al. (2011). MicroRNA-134 plasma levels before and after treatment for bipolar mania. J. Psychiatr. Res. 45, 92-95. doi: 10.1016/j.jpsychires.2010.04.028.
113. Rossi, M., Kilpinen, H., Muona, M., Surakka, I., Ingle, C., Lahtinen, J., et al. (2013). Allele-specific regulation of DISC1 expression by miR-135b-5p. Eur. J. Hum. Genet. doi: 10.1038/ejhg.2013.246. [Epub ahead ofprint].
114. Santarelli, D. M., Beveridge, N. J., Tooney, P. A., and Cairns, M. J. (2011). Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry 69, 180-187. doi: 10.1016/j.biopsych.2010.09.030.
115. Santarelli, D. M., Liu, B., Duncan, C. E., Beveridge, N. J., Tooney, P. A., Schofield, P. R., et al. (2013). Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine. Psychopharmacology 227, 67-78. doi: 10.1007/s00213-012-2939-y
116. Saus, E., Soria, V., Escaramis, G., Vivarelli, F., Crespo, J. M., Kagerbauer, B., et al. (2005). Genetic variants and abnormal processing ofpre-miR-182, a circadian clock modulator, in major depression patients with late insomnia. Hum. Mol. Genet. 19, 4017-4025. doi: 10.1093/hmg/ddq316
117. Sayed, D., and Abdellatif, M. (2011). MicroRNAs in development and disease. Physiol. Rev. 91, 827-887. doi: 10.1152/physrev.00006.2010.
118. Scarr, E., Craig, J. M., Cairns, M. J., Seo, M. S., Galati, J. C., Beveridge, N. J., et al. (2006). Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA. Transl. Psychiatry 3, e230. doi: 10.1038/tp.2013.3.
119. Schiffman, J. D., Lorimer, P. D., Rodic, V., Jahromi, M. S., Downie, J. M., Bayerl, M.,et al. (2011). Genome wide copynumber analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. Br. J. Haematol. 14, 477-486. doi: 10.1111/j.1365-2141.2011.08883.x
120. Schipper, H. M., Maes, O. C., Chertkow, H. M., and Wang, E. (2007). MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Bio. 1, 263-274.
121. Schonrock, N., Ke, Y. D., Humphreys, D., Staufenbiel, M., Ittner, L. M., Preiss, T., et al. (2010). Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS ONE 5:e11070. doi: 10.1371/journal.pone. 0011070
122. Schwarz, D. S., Hutvagner, G., Du, T., Xu, Z., Aronin, N., and Zamore, P. D. (2003). Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208. doi: 10.1016/S0092-8674(03)00759-1.
123. Serpente, M., Fenoglio, C., Villa, C., Cortini, F., Cantoni, C., Ridolfi, E., et al. (2007).Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis. J. Alzheimers Dis. 26, 787-793. doi: 10.3233/JAD-2011-110074
124. Sethupathy, P., and Collins, F. S. (2008). MicroRNA target site polymorphisms and human disease. Trends Genet. 24, 489-497. doi: 10.1016/j.tig.2008. 07.004
125. Shaltiel, G., Hanan, M., Wolf, Y., Barbash, S., Kovalev, E., Shoham, S., et al. (2013). Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target. Brain Struct. Funct. 218, 59-72. doi: 10.1007/s00429-011-0376-z
126. Sheinerman, K. S., Tsivinsky, V. G., Crawford, F., Mullan, M. J., Abdullah, L., and Umansky, S. R. (2012). Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY). 4, 590-605.
127. Shi, W., Du, J., Qi, Y., Liang, G., Wang, T., Li, S., et al. (2012). Aberrant expression of serum miRNAs in schizophrenia. J. Psychiatr. Res. 46, 198-204. doi: 10.1016/j.jpsychires.2011.09.010.
128. Shim, S. M., Nam, H. Y., Lee, J. E., Kim, J. W., Han, B. G., and Jeon, J. P. (2012). MicroRNAs in human lymphoblastoid cell lines. Crit. Rev. Eukaryot. Gene. Expr. 14, 189-196. doi: 10.1615/CritRevEukarGeneExpr.v22.i3.20.
129. Siegel, G., Saba, R., and Schratt, G. (2011). microRNAs in neurons: manifold regulatory roles at the synapse. Curr. Opin. Genet. Dev. 21, 491-497. doi: 10.1016/j.gde.2011.04.008.
130. Skog, J., Wurdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Sena-Esteves, M., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provi.de diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476. doi: 10.1038/ncb1800.
131. Smalheiser, N. R., and Lugli, G. (2009). microRNA regulation of synaptic plasticity. Neuromolecular Med. 11, 133-140. doi: 10.1007/s12017-009-8065-2.
132. Smalheiser, N. R., Lugli, G., Rizavi, H. S., Torvik, V. I., Turecki, G., and Dwivedi, Y. (2007).MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS ONE 7:e33201. doi: 10.1371/jour-nal.pone.0033201
133. Soreq, L., Salomonis, N., Bronstein, M., Greenberg, D. S., Israel, Z., Bergman, A.,et al. (2013). Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation induced splicing changes that classify brain region transcriptomes. Front. Mol. Neurosci. 6:10. doi: 10.3389/fnmol.2013.00010.
134. Tan, L., Yu, J. T., Hu, N., and Tan, L. (2013). Non-coding RNAs in Alzheimer's disease. Mol. Neurobiol. 47, 382-393. doi: 10.1007/s12035-012-8359-5.
135. Tan, L., Yu, J. T., Liu, Q. Y., Tan, M. S., Zhang, W., Hu, N., et al. (2014). Circulating miR-125b as a biomarker of Alzheimer's disease. J. Neurol. Sci. 336, 52-56. doi: 10.1016/j.jns.2013.10.002.
136. Tardito, D., Mallei, A., and Popoli, M. (2013). Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs. Expert Opin. Investig. Drugs 22,217-233. doi: 10.1517/13543784.2013.749237.
137. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007). Exosome mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596
138. Van Deerlin, V. M., Sleiman, P. M., Martinez-Lage, M., Chen-Plotkin, A., Wang, L. S., Graff-Radford, N. R., et al. (2010). Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 42, 234-239. doi: 10.1038/ng.536
139. van Spronsen, M., van Battum, E. Y., Kuijpers, M., Vangoor, V. R., Rietman, M. L., Pothof, J., et al. (2013). Developmental and activity-dependent miRNA expression profiling in primary hippocampal neuron cultures. PLoS ONE 8:e74907. doi: 10.1371/journal.pone.0074907.
140. Villa, C., Fenoglio, C., De Riz, M., Clerici, F., Marcone, A., Benussi, L., et al. (2008). Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration. Rejuvenation Res. 14, 275-281. doi: 10.1089/rej.2010.1123.
141. Wang, G., van der Walt, J. M., Mayhew, G., Li, Y. J., Zuchner, S., Scott, W. K., et al. (2008b). Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet. 82, 283-289. doi: 10.1016/j.ajhg.2007.09.021.
142. Wang, K., Zhang, S., Weber, J., Baxter, D., and Galas, D. J. (2010a). Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic AcidsRes. 38, 7248-7259. doi: 10.1093/nar/gkq601.
143. Wang, W. X., Huang, Q., Hu, Y., Stromberg, A. J., and Nelson, P. T. (2011). Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 121, 193-205. doi: 10.1007/s00401-010-0756-0.
144. Wang, W. X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., et al. (2008a). The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28, 1213-1223. doi: 10.1523/JNEUROSCI.5065-07.2008.
145. Wang, W. X., Wilfred, B. R., Madathil, S. K., Tang, G., Hu, Y., Dimayuga, J., et al. (2010b). miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am. J. Pathol. 177, 334-345. doi: 10.2353/ajpath.2010.091202.
146. Wibrand, K., Pai, B., Siripornmongcolchai, T., Bittins, M., Berentsen, B., Ofte, M. L., et al. (2012). MicroRNA regulation of the synaptic plasticity-related gene Arc. PLoS ONE 7:e41688. doi: 10.1371/journal.pone.0041688.
147. Xu, Y., Li, F., Zhang, B., Zhang, K., Zhang, F., Huang, X., et al. (2010a). MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia. Schizophr. Res. 119, 219-227. doi: 10.1016/j.schres.2010.02.1070.
148. Xu, Y., Liu, H., Li, F., Sun, N., Ren, Y., Liu, Z., et al. (2010b). A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform. J. Affect. Disord. 127, 332-336. doi: 10.1016/j.jad.2010. 05.019
149. Zeng, L., Liu, J., Wang, Y., Wang, L., Weng, S., Tang, Y., et al. (2011). MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front. Biosci. (Elite. Ed.) 3:330. doi: 10.2741/330.
150. Zhou, R., Yuan, P., Wang, Y., Hunsberger, J. G., Elkahloun, A., Wei, Y., et al. (2009). Evidence for selective microRNAs and their effectors as common longterm targets for the actions of mood stabilizers. Neuropsychopharmacology 34, 1395-1405. doi: 10.1038/npp.2008.131.
151. Zhou, Y., Wang, J., Lu, X., Song, X., Ye, Y., Zhou, J., et al. (2013). Evaluation of six SNPs of MicroRNA machinery genes and risk of schizophrenia. J. Mol. Neurosci. 49, 594-599. doi: 10.1007/s12031-012-9887-1.
152. Ziats, M. N., and Rennert, O. M. (2013). Identification of differentially expressed microRNAs across the developing human brain. Mol. Psychiatry. doi: 10.1038/ mp.2013.93. [Epub ahead ofprint].
153. Zovoilis, A., Agbemenyah, H. Y., Agis-Balboa, R. C., Stilling, R. M., Edbauer, D., Rao, P., et al. (2011). microRNA-34c is a novel target to treat dementias. EMBO J. 30, 4299-4308. doi: 10.1038/emboj.2011.327.
154. Zubakov, D., Boersma, A. W., Choi, Y., van Kuijk, P. F., Wiemer, E. A., and Kayser, M. (2010). MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int. J. Legal Med. 124, 217-226. doi: 10.1007/s00414-009-0402-3